UNCY•benzinga•
Unicycive Provides Update On New Drug Application for Oxylanthanum Carbonate To Treat Hyperphosphatemia In Patients With Chronic Kidney Disease On Dialysis; Says FDA to provide final decision by PDUFA Action Date Of June 28, 2025
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 10, 2025 by benzinga